Mai concret, oficialii ARPIM arat\u0103 c\u0103, \u00een acest caz, cauzele care au determinat decizia au fost: perioada foarte lung\u0103 de timp \u00een care listele de medicamente compensate \u015fi gratuite nu au fost completate cu molecule noi, inovatoare, pre\u0163urile impuse la nivel minim european, referen\u0163ierea pre\u0163urilor produselor originale la cele generice, introducerea pe listele de gratuite \u015fi compensate a unor produse care, de\u015fi nu se afl\u0103 la dispozi\u0163ia real\u0103 a pacien\u0163ilor, au avut ca efect cre\u015fterea copl\u0103\u0163ii suportate \u00een fapt tot de c\u0103tre companie, prelungirea termenelor de \u00eencasare a banilor de c\u0103tre produc\u0103tori la peste 300 de zile \u015fi \u00een final taxa clawback.<\/p>\n
“La sf\u00e2r\u015fitul anului trecut, Mundipharma a luat decizia de a-\u015fi restr\u00e2nge activitatea de reprezentare direct\u0103 \u00een Rom\u00e2nia, precum \u015fi de a c\u0103uta o nou\u0103 alternativ\u0103 de business pe plan local. \u00cen acest context, este important de re\u0163inut c\u0103, de\u015fi au existat unele discontinuit\u0103\u0163i \u00een aprovizionare, produsele Mundipharma vor fi \u015fi \u00een continuare la dispozi\u0163ia medicilor \u015fi a pacien\u0163ilor rom\u00e2ni”, spune Cristian Lu\u0163an, director executiv adjunct al ARPIM.<\/p>\n
ARPIM reitereaz\u0103 faptul c\u0103 taxa clawback, cumulat\u0103 cu celelalte m\u0103suri de austeritate – neactualizarea integral\u0103 a listei medicamentelor compensate din 2008, termenele de plat\u0103 foarte lungi, cel mai mic pre\u0163 la medicamente din \u00eentreaga Europ\u0103, referen\u0163ierea pe clase terapeutice – creaz\u0103 un mediu economic \u015fi investi\u0163ional impredictibil \u015fi extrem de dificil.<\/p>\n
“Aceasta este realitatea economic\u0103 de care trebuie s\u0103 \u0163inem cont atunci c\u00e2nd lu\u0103m decizii referitoare la activitatea noastr\u0103 \u00een Rom\u00e2nia. Companiile farmaceutice membre ARPIM nu au amenin\u0163at \u015fi nu amenin\u0163\u0103 cu retragerea din Rom\u00e2nia. Nu avem cuno\u015ftin\u0163\u0103 ca \u00een intervalul imediat urm\u0103tor alte companii ARPIM s\u0103-\u015fi fi anun\u0163at retragerea din Rom\u00e2nia. ARPIM, al\u0103turi de membrii s\u0103i, vor informa autorit\u0103\u0163ile \u015fi pacien\u0163ii \u00een cazul \u00een care vor fi \u015fi alte companii nevoite s\u0103 se retrag\u0103. Companiile farmaceutice, a\u015fa cum este Mundipharma \u00een aceste zile, sunt nevoite s\u0103 ac\u0163ioneze \u00een condi\u0163ii economice profund nefavorabile \u015fi s\u0103 ia deciziile care se impun de la companie la companie”, se arat\u0103 \u00een comunicatul de pres\u0103 remis BUSINESS Magazin.<\/p>\n
Asocia\u0163ia Rom\u00e2n\u0103 a Produc\u0103torilor Interna\u0163ionali de Medicamente (ARPIM) este organiza\u0163ia care sus\u0163ine obiectivele comune ale celor mai importante 28 de companii farmaceutice interna\u0163ionale produc\u0103toare de medicamente originale, prezente \u00een Rom\u00e2nia. Acestea realizeaz\u0103 \u00eempreun\u0103 peste 70% din valoarea pie\u0163ei farmaceutice rom\u00e2ne\u015fti.<\/p>\n","protected":false},"excerpt":{"rendered":"
Asocia\u0163ia Rom\u00e2n\u0103 a Produc\u0103torilor Interna\u0163ionali de Medicamente (ARPIM) sus\u0163ine c\u0103 decizia companei Mundipharma, unicul furnizor de morfin\u0103 al unit\u0103\u0163ilor spitalice\u015fti, de a-\u015fi restr\u00e2nge activitatea de reprezentare direct\u0103 \u00een Rom\u00e2nia s-a bazat pe \u00een\u0103sprirea considerabil\u0103 a condi\u0163iilor de desf\u0103\u015furare a activit\u0103\u0163ii pe pia\u0163a farmaceutic\u0103 rom\u00e2neasc\u0103, pe cre\u015fterea considerabil\u0103 a expunerii la riscuri financiare, precum \u015fi pe cre\u015fterea nesustenabil\u0103 a nivelului de taxare.<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[511],"tags":[201,26768,8088,10222],"class_list":["post-53950","post","type-post","status-publish","format-standard","hentry","category-afaceri","tag-companii","tag-cristian-lutan","tag-farma","tag-retragere"],"_links":{"self":[{"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=\/wp\/v2\/posts\/53950","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=53950"}],"version-history":[{"count":1,"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=\/wp\/v2\/posts\/53950\/revisions"}],"predecessor-version":[{"id":70579,"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=\/wp\/v2\/posts\/53950\/revisions\/70579"}],"wp:attachment":[{"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=53950"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=53950"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=53950"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}